Samsung Biologics Reports First Quarter 2026 Financial Results

Samsung Biologics Reports First Quarter 2026 Financial Results

Summary

**media[1023780]**Recorded Q1'26 revenue of KRW 1,257 billion and operating profit of KRW 581 billionPerformance driven by full utilization across Plants 1 thro...

Description

**media[1023780]**Recorded Q1'26 revenue of KRW 1,257 billion and operating profit of KRW 581 billionPerformance driven by full utilization across Plants 1 thro...

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source

Related coverage